Rockville, MD [September 8, 2022] – US Fertility, the nation’s largest partnership of physician-owned and physician-led top-tier fertility practices, is proud to launch the US Fertility Innovation Fund. The Innovation Fund will identify, evaluate, and invest in early-stage ventures that have the potential to shape the future of the fertility field and improve access to and the quality of patient care.
“The US Fertility Innovation Fund is an exciting opportunity to stay at the cutting edge of science and participate as investors and thought partners in the future of our field of medicine,” shares Eduardo Hariton, M.D., MBA, USF’s VP of Strategic Initiatives and Managing Director of the US Fertility Innovation Fund. “I am thankful for the opportunity to help our organization evaluate, invest in, and implement solutions that improve the quality, efficiency, and service level of the care that USF patients receive.”
Dr. Hariton is a practicing, board-eligible, reproductive endocrinologist and fertility physician at Reproductive Science Center of the Bay Area, a founding partner practice of US Fertility, where he combines his clinical and business backgrounds to treat patients and think creatively about how to improve the care they receive when seeking fertility services.
The Innovation Fund is structured around key objectives that include evaluating promising trends in fertility, driving adoption of emerging technologies across the US Fertility network of practices, and offering providers opportunities for co-investment. US Fertility physicians and management are offered the opportunity to invest alongside US Fertility as limited partners of the fund.
“As the nation’s largest physician-led fertility network, US Fertility is proud to offer our physician team members and other shareholders an innovative and cutting-edge opportunity to collectively shape the future of our field of medicine,” shares Mark Segal, CEO, US Fertility.
The US Fertility Innovation Fund has already made several investments. The fund continues to actively explore investments in patient experience platforms, at-home testing technologies, and other early-stage startups.
US Fertility is always seeking innovators in the field of reproductive medicine. If you have an idea or early-stage start-up that has the potential to improve treatment outcomes, enhance the patient experience, or expand access to care, please reach out to email@example.com.